231 related articles for article (PubMed ID: 28359780)
1. Potential role of retinoids in ovarian physiology and pathogenesis of polycystic ovary syndrome.
Jiang Y; Li C; Chen L; Wang F; Zhou X
Clin Chim Acta; 2017 Jun; 469():87-93. PubMed ID: 28359780
[TBL] [Abstract][Full Text] [Related]
2. Hormone-induced rat model of polycystic ovary syndrome: A systematic review.
Noroozzadeh M; Behboudi-Gandevani S; Zadeh-Vakili A; Ramezani Tehrani F
Life Sci; 2017 Dec; 191():259-272. PubMed ID: 29055801
[TBL] [Abstract][Full Text] [Related]
3. Defects in insulin signaling pathways in ovarian steroidogenesis and other tissues in polycystic ovary syndrome (PCOS).
Diamanti-Kandarakis E; Argyrakopoulou G; Economou F; Kandaraki E; Koutsilieris M
J Steroid Biochem Mol Biol; 2008 Apr; 109(3-5):242-6. PubMed ID: 18440223
[TBL] [Abstract][Full Text] [Related]
4. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
5. Comprasion of ovarian stromal blood flow measured by color Doppler ultrasonography in polycystic ovary syndrome patients and healthy women with ultrasonographic evidence of polycystic.
Ozdemir O; Sari ME; Kalkan D; Koc EM; Ozdemir S; Atalay CR
Gynecol Endocrinol; 2015 Apr; 31(4):322-6. PubMed ID: 25558942
[TBL] [Abstract][Full Text] [Related]
6. Recent updates on animal models for understanding the etiopathogenesis of polycystic ovarian syndrome.
Corrie L; Gulati M; Singh SK; Kapoor B; Khursheed R; Awasthi A; Vishwas S; Chellappan DK; Gupta G; Jha NK; Anand K; Dua K
Life Sci; 2021 Sep; 280():119753. PubMed ID: 34171379
[TBL] [Abstract][Full Text] [Related]
7. [Ovarian insulin resistance and insulin sensitizer effect on polycystic ovary syndrome].
Wu XK; Risto E
Zhonghua Fu Chan Ke Za Zhi; 2004 Dec; 39(12):804-8. PubMed ID: 15733404
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of ovarian reserve in women with polycystic ovary syndrome.
Huddleston HG
Semin Reprod Med; 2013 Nov; 31(6):452-61. PubMed ID: 24101226
[TBL] [Abstract][Full Text] [Related]
9. [Polycystic ovary syndrome in 2006].
Vrbíková J; Bendlová B
Cas Lek Cesk; 2007; 146(3):218-22. PubMed ID: 17419303
[TBL] [Abstract][Full Text] [Related]
10. [Anti-Mullerian hormone- its role in the pathogenesis of the polycystic ovary syndrome].
Parahuleva N; Pehlivanov B; Dimitrakova E; Malinova M; Mladenova M
Akush Ginekol (Sofiia); 2012; 51(6):22-6. PubMed ID: 23390860
[TBL] [Abstract][Full Text] [Related]
11. Polycystic ovary syndrome in adolescence.
Blank SK; Helm KD; McCartney CR; Marshall JC
Ann N Y Acad Sci; 2008; 1135():76-84. PubMed ID: 18574211
[TBL] [Abstract][Full Text] [Related]
12. The role of the central nervous system in the pathogenesis of polycystic ovary syndrome.
Hayden BJ; Balen AH
Minerva Ginecol; 2006 Feb; 58(1):41-54. PubMed ID: 16498370
[TBL] [Abstract][Full Text] [Related]
13. Polycystic ovary syndrome: evidence for a primary disorder of ovarian steroidogenesis.
Franks S; Gharani N; Gilling-Smith C
J Steroid Biochem Mol Biol; 1999; 69(1-6):269-72. PubMed ID: 10419001
[TBL] [Abstract][Full Text] [Related]
14. Physiological and pathological implications of retinoid action in the endometrium.
Jiang Y; Chen L; Taylor RN; Li C; Zhou X
J Endocrinol; 2018 Mar; 236(3):R169-R188. PubMed ID: 29298821
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of insulin resistance in polycystic ovary syndrome.
Diamanti-Kandarakis E; Papavassiliou AG
Trends Mol Med; 2006 Jul; 12(7):324-32. PubMed ID: 16769248
[TBL] [Abstract][Full Text] [Related]
16. Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis.
Wood JR; Dumesic DA; Abbott DH; Strauss JF
J Clin Endocrinol Metab; 2007 Feb; 92(2):705-13. PubMed ID: 17148555
[TBL] [Abstract][Full Text] [Related]
17. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
[TBL] [Abstract][Full Text] [Related]
18. Development of polycystic ovary syndrome: involvement of genetic and environmental factors.
Franks S; McCarthy MI; Hardy K
Int J Androl; 2006 Feb; 29(1):278-85; discussion 286-90. PubMed ID: 16390494
[TBL] [Abstract][Full Text] [Related]
19. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle.
Lockwood GM; Muttukrishna S; Groome NP; Matthews DR; Ledger WL
J Clin Endocrinol Metab; 1998 May; 83(5):1730-5. PubMed ID: 9589683
[TBL] [Abstract][Full Text] [Related]
20. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.
Nardo LG; Patchava S; Laing I
Panminerva Med; 2008 Dec; 50(4):267-78. PubMed ID: 19078868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
